Clinical Trials Browser

Withdrawn × Leukoplakia, Oral × Clear all

NCT05505539 2022-09-22

OL_5FU

Phase 1 Withdrawn

Leukoplakia, Oral

NCT03939364 2021-10-19

This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions

Phase 1 Withdrawn

Erythroplasia, Leukoplakia, Oral